Hikma Pharmaceuticals Plc Stock Filter Stocks by Fundamentals
HKMPY Stock | USD 46.50 0.00 0.00% |
Hikma Pharmaceuticals PLC fundamentals help investors to digest information that contributes to Hikma Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Hikma Pink Sheet. The fundamental analysis module provides a way to measure Hikma Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hikma Pharmaceuticals pink sheet.
Hikma |
Did you try this?
Run AI Investment Finder Now
AI Investment FinderUse AI to screen and filter profitable investment opportunities |
All Next | Launch Module |
Hikma Fundamentals
Return On Equity | 0.15 | |||
Return On Asset | 0.077 | |||
Profit Margin | 0.14 % | |||
Operating Margin | 0.22 % | |||
Current Valuation | 5.26 B | |||
Shares Outstanding | 110.13 M | |||
Price To Earning | 10.10 X | |||
Price To Book | 1.89 X | |||
Price To Sales | 1.60 X | |||
Revenue | 2.55 B | |||
Gross Profit | 1.3 B | |||
EBITDA | 759 M | |||
Net Income | 421 M | |||
Cash And Equivalents | 393 M | |||
Cash Per Share | 3.57 X | |||
Total Debt | 651 M | |||
Debt To Equity | 0.71 % | |||
Current Ratio | 2.12 X | |||
Book Value Per Share | 19.77 X | |||
Cash Flow From Operations | 638 M | |||
Earnings Per Share | 2.99 X | |||
Price To Earnings To Growth | 2.41 X | |||
Number Of Employees | 8.7 K | |||
Beta | 0.35 | |||
Market Capitalization | 4.72 B | |||
Total Asset | 4.37 B | |||
Retained Earnings | 1.16 B | |||
Working Capital | 701 M | |||
Current Asset | 1.57 B | |||
Current Liabilities | 866 M | |||
Z Score | 4.2 | |||
Annual Yield | 0.03 % | |||
Five Year Return | 1.79 % | |||
Net Asset | 4.37 B | |||
Last Dividend Paid | 0.55 |
About Hikma Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hikma Pharmaceuticals PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hikma Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hikma Pharmaceuticals PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hikma Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hikma Pharmaceuticals' short interest history, or implied volatility extrapolated from Hikma Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hikma Pharmaceuticals PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Hikma Pink Sheet analysis
When running Hikma Pharmaceuticals' price analysis, check to measure Hikma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hikma Pharmaceuticals is operating at the current time. Most of Hikma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hikma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hikma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hikma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |